MX2019007494A - Metodo para modular el crecimiento de celulas madre hematopoyeticas. - Google Patents

Metodo para modular el crecimiento de celulas madre hematopoyeticas.

Info

Publication number
MX2019007494A
MX2019007494A MX2019007494A MX2019007494A MX2019007494A MX 2019007494 A MX2019007494 A MX 2019007494A MX 2019007494 A MX2019007494 A MX 2019007494A MX 2019007494 A MX2019007494 A MX 2019007494A MX 2019007494 A MX2019007494 A MX 2019007494A
Authority
MX
Mexico
Prior art keywords
hsc
stem cell
hematopoietic stem
modulators
cell growth
Prior art date
Application number
MX2019007494A
Other languages
English (en)
Inventor
I Zon Leonard
E North Trista
GOESSLING Wolfran
Original Assignee
Children´S Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Children´S Medical Center Corp filed Critical Children´S Medical Center Corp
Publication of MX2019007494A publication Critical patent/MX2019007494A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/02—Compounds of the arachidonic acid pathway, e.g. prostaglandins, leukotrienes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La presente invención proporciona composiciones y métodos para modular poblaciones de células madre hematopoyéticas al utilizar moduladores de HSC, que son agentes que ya sea que incrementan los números de HSC o disminuyen los números de HSC como sea deseado por una indicación particular. Por ejemplo, los moduladores de HSC encontrados para incrementar los números de HSC incluyen prostaglandina E2 (PGE2) y agentes que estimulan la ruta de PGE2. A la inversa, los moduladores que previenen la síntesis de PGE2 disminuyen los números de HSC. Los moduladores de HSC pueden ser utilizados in vitro, in vivo o ex vivo.
MX2019007494A 2006-03-24 2008-09-23 Metodo para modular el crecimiento de celulas madre hematopoyeticas. MX2019007494A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78596806P 2006-03-24 2006-03-24

Publications (1)

Publication Number Publication Date
MX2019007494A true MX2019007494A (es) 2019-09-06

Family

ID=38526581

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2008012178A MX2008012178A (es) 2006-03-24 2007-03-26 Metodo para modular el crecimiento de celulas madre hematopoyeticas.
MX2019007494A MX2019007494A (es) 2006-03-24 2008-09-23 Metodo para modular el crecimiento de celulas madre hematopoyeticas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2008012178A MX2008012178A (es) 2006-03-24 2007-03-26 Metodo para modular el crecimiento de celulas madre hematopoyeticas.

Country Status (11)

Country Link
US (7) US8168428B2 (es)
EP (3) EP2423303A1 (es)
JP (8) JP5247675B2 (es)
CN (2) CN102626517B (es)
AU (1) AU2007230902B2 (es)
CA (1) CA2647201C (es)
HK (1) HK1173948A1 (es)
MX (2) MX2008012178A (es)
RU (2) RU2425876C2 (es)
WO (1) WO2007112084A2 (es)
ZA (2) ZA200808123B (es)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2425876C2 (ru) 2006-03-24 2011-08-10 Чилдрен'З Медикал Сентер Корпорейшн Способ модулирования роста гематопоэтических стволовых клеток
US9402852B2 (en) 2006-10-20 2016-08-02 Children's Medical Center Corporation Method to enhance tissue regeneration
US9394520B2 (en) 2006-12-08 2016-07-19 University Of Rochester Expansion of hematopoietic stem cells
WO2008133904A1 (en) * 2007-04-23 2008-11-06 Stowers Institute For Medical Research Methods and compositions for stem cell self-renewal
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
ITUD20080058A1 (it) * 2008-03-18 2009-09-19 Thankstem S R L Kit per la raccolta di sangue, preferibilmente periferico, per la produzione di cellule staminali
US20110206781A1 (en) * 2008-05-28 2011-08-25 Zon Leonard I Method to modulate hematopoietic stem cell growth
EP3824884A1 (en) 2008-11-06 2021-05-26 Indiana University Research and Technology Corporation Materials and methods to enhance hematopoietic stem cells engraftment procedures
WO2010096264A2 (en) 2009-02-03 2010-08-26 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
WO2010091052A2 (en) 2009-02-03 2010-08-12 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
US20120202288A1 (en) * 2009-03-19 2012-08-09 Fate Therapeutics, Inc. Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same
US20120195862A1 (en) * 2009-04-17 2012-08-02 Children's Medical Center Corporation Biomechanical induction of hematopoiesis
EP2251010A1 (en) 2009-05-08 2010-11-17 Sygnis Bioscience GmbH & Co. KG Use of thiabendazole and derivatives thereof for the therapy of neurological conditions
EP3575394A1 (en) * 2009-11-15 2019-12-04 Indiana University Research&Technology Corporation Methods to enhance delivery and engraftment of stem cells including the identification of specific prostaglandin e2 receptors
US20130129686A1 (en) * 2009-11-19 2013-05-23 Regents Of The University Reducing Inflammation Using Cell Therapy
WO2011143125A2 (en) * 2010-05-10 2011-11-17 Fate Therapeutics, Inc. Biovessels
WO2012021845A2 (en) * 2010-08-12 2012-02-16 Fate Therapeutics, Inc. Improved hematopoietic stem and progenitor cell therapy
EA033717B1 (ru) 2011-01-13 2019-11-19 Scipharm Sarl Способ ex vivo предварительной обработки гемопоэтических стволовых клеток и фармацевтическая композиция для улучшения приживления гемопоэтических стволовых клеток
US9592236B2 (en) * 2011-04-28 2017-03-14 Duke University Methods of treating hemoglobinopathies
KR102011532B1 (ko) 2011-09-30 2019-08-16 블루버드 바이오, 인코포레이티드. 개선된 바이러스 형질도입을 위한 화합물
CN112375734A (zh) 2011-12-02 2021-02-19 菲特治疗公司 增强的干细胞组合物
ES2682255T3 (es) 2011-12-02 2018-09-19 Fate Therapeutics, Inc. Métodos mejorados de tratamiento de isquemia
EP2788475A1 (en) 2011-12-05 2014-10-15 Primorigen Biosciences Inc. Compositions and methods for differentiating pluripotent stem cells into primitive blood cells and uses thereof
WO2014015318A1 (en) * 2012-07-19 2014-01-23 Bluebird Bio, Inc. Soluble compounds for improved gene therapy methods
WO2014081760A1 (en) 2012-11-20 2014-05-30 Duke University Methods of treating hemoglobinopathies
US9943545B2 (en) * 2013-03-15 2018-04-17 Fate Therapeutics, Inc. Stem cell culture media and methods of enhancing cell survival
WO2014150602A1 (en) 2013-03-15 2014-09-25 Fate Therapeutics, Inc. Cell potency assay for therapeutic potential
US9428748B2 (en) * 2013-06-17 2016-08-30 Hong Gao Method of expanding hematopoietic stem cells
JP2015205835A (ja) * 2014-04-21 2015-11-19 国立大学法人福井大学 中性子線障害防護剤
EP3134096A4 (en) * 2014-04-23 2018-01-10 Texas Heart Institute Methods of enhancing stem cell engraftment
WO2016014794A1 (en) 2014-07-25 2016-01-28 Sangamo Biosciences, Inc. Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells
RS62334B1 (sr) 2014-09-16 2021-10-29 Sangamo Therapeutics Inc Postupci i sastavi za inženjering genoma posredovan nukleazom i korekciju kod matičnih ćelija hematopoeze
CA2974381A1 (en) 2015-01-26 2016-08-04 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
JP6980534B2 (ja) 2015-06-25 2021-12-15 ザ チルドレンズ メディカル センター コーポレーション 造血幹細胞の増大、富化、および維持に関する方法および組成物
RU2018106515A (ru) 2015-07-21 2019-08-21 Зе Чилдрен'С Медикал Сентер Корпорейшн Pd-l1-экспрессирующие гемопоэтические стволовые клетки и применения
CN105296427A (zh) * 2015-10-23 2016-02-03 深圳爱生再生医学科技有限公司 造血干细胞的体外扩增培养方法
WO2017073692A1 (ja) * 2015-10-30 2017-05-04 国立大学法人鳥取大学 メチル化関連酵素ｈａｔ１とｋａｔ８の阻害薬
ES2953925T3 (es) 2015-11-04 2023-11-17 Fate Therapeutics Inc Ingeniería genómica de células pluripotentes
EP3371301A4 (en) 2015-11-04 2019-06-26 Fate Therapeutics, Inc. METHOD AND COMPOSITIONS FOR INDUCING THE DIFFERENTIATION OF HEMATOPOIETIC CELLS
CN108883136A (zh) 2016-02-12 2018-11-23 蓝鸟生物公司 Vcn增强子组合物及其使用方法
EP3414321B8 (en) 2016-02-12 2023-05-03 bluebird bio, Inc. Vcn enhancer compositions and methods of using the same
EP3423067A4 (en) * 2016-03-04 2019-09-04 The Board of Trustees of the Leland Stanford Junior University COMPOSITIONS AND METHODS FOR MUSCLE REGENERATION USING PROSTAGLANDIN E2
US9918994B2 (en) 2016-03-04 2018-03-20 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for muscle regeneration using prostaglandin E2
AU2017235461B2 (en) 2016-03-15 2023-02-23 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion
US11229662B2 (en) 2016-11-15 2022-01-25 The Schepens Eye Research Institute, Inc. Compositions and methods for the treatment of aberrant angiogenesis
WO2018226797A1 (en) * 2017-06-07 2018-12-13 Academia Sinica Method for removing undifferentiated pluripotent stem cells
EP3634424A4 (en) 2017-06-09 2021-06-09 The Board of Trustees of the Leland Stanford Junior University COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS
EP3672590A4 (en) * 2017-08-22 2021-04-28 The Children's Medical Center Corporation METHOD FOR INDUCING HEMATOPOETIC STEM CELL SPECIFICITY
WO2019060708A1 (en) 2017-09-22 2019-03-28 The Children's Medical Center Corporation TREATMENT OF TYPE 1 DIABETES AND AUTOIMMUNE DISEASES OR DISORDERS
US11739326B2 (en) 2017-11-14 2023-08-29 Massachusetts Eye And Ear Infirmary RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition
EP3597211A1 (en) * 2018-07-19 2020-01-22 Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus Periostin compounds for the treatment of haematological complications
CN109609455A (zh) * 2018-12-28 2019-04-12 诺未科技（北京）有限公司 扩增造血干细胞的培养体系、方法及其用途
WO2020167948A1 (en) * 2019-02-13 2020-08-20 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for stem cell therapy
CN110051839A (zh) * 2019-04-16 2019-07-26 诺航生物技术(徐州)有限公司 一种促进脐带血干细胞体外扩增和增强脐带血干细胞移植后造血重建功能的药物
US20230193212A1 (en) 2020-05-06 2023-06-22 Orchard Therapeutics (Europe) Limited Treatment for neurodegenerative diseases
US11883436B2 (en) 2020-08-17 2024-01-30 The Board Of Trustees Of The University Of Illinois Method of preparing hematopoietic stem and progenitor cells for transplantation
AU2021202658A1 (en) 2021-04-28 2022-11-17 Fondazione Telethon Gene therapy
GB202206346D0 (en) 2022-04-29 2022-06-15 Ospedale San Raffaele Srl Gene therapy
KR20240136869A (ko) 2023-03-07 2024-09-19 인제대학교 산학협력단 조혈 줄기세포 증식 또는 가동화 촉진용 조성물 및 가동화 조혈 줄기세포 수집방법

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA103846A (en) 1906-12-03 1907-02-26 William Bell Manufacture of half-tone printing blocks
US3217903A (en) 1961-01-19 1965-11-16 Mc Graw Edison Co Segregating control
US3753357A (en) 1970-12-14 1973-08-21 Ovitron Res Corp Method and apparatus for the preservation of cells and tissues
US4199022A (en) 1978-12-08 1980-04-22 The United States Of America As Represented By The Department Of Energy Method of freezing living cells and tissues with improved subsequent survival
US4239679A (en) 1979-06-27 1980-12-16 Diamond Shamrock Corporation High bulk density rigid poly(vinyl chloride) resin powder composition and preparation thereof
HU181154B (en) 1980-07-18 1983-06-28 Epitestudomanyi Intezet Shaped building unit and space limiting or dividing structure made of same as well as method for producing the shaped building unit
US4559298A (en) 1982-11-23 1985-12-17 American National Red Cross Cryopreservation of biological materials in a non-frozen or vitreous state
US5004681B1 (en) 1987-11-12 2000-04-11 Biocyte Corp Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
EP1241258A3 (en) * 1989-10-16 2003-12-10 Amgen Inc. Stem cell factor
US5114672A (en) 1990-08-27 1992-05-19 Cryo-Cell International, Inc. Method for preserving blood fluid
JPH09505462A (ja) * 1993-08-23 1997-06-03 バクスター、インターナショナル、インコーポレイテッド 無血清培地内での好中球前駆細胞及び巨核球前駆細胞の試験管内増殖
WO1996040866A1 (en) * 1995-06-07 1996-12-19 Novartis Ag Serum-free media for primitive hematopoietic cells and methods of use thereof
US6372796B1 (en) 1996-11-13 2002-04-16 Cold Spring Harbor Laboratory Therapeutic uses for nitric oxide inhibitors
GB9904281D0 (en) 1999-02-24 1999-04-21 Reneuron Ltd Transplantation
BR0015781A (pt) 1999-11-24 2002-12-31 Ono Pharmaceutical Co Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea
TWI247606B (en) 1999-11-24 2006-01-21 Ono Pharmaceutical Co Treating agent for osteopenic diseases
US6226997B1 (en) 1999-12-07 2001-05-08 Cryo-Cell International, Inc. Method and device for maintaining temperature integrity of cryogenically preserved biological samples
US6852534B2 (en) 2000-11-03 2005-02-08 Kourion Therapeutics Gmbh Method to determine an engrafting cell dose of hematopoietic stem cell transplant units
JP4077158B2 (ja) 2001-01-10 2008-04-16 株式会社メニコン 植物性繊維分解剤およびそれを用いた植物性廃棄物の処理法
CA2438153C (en) 2001-02-14 2015-06-02 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
FR2825261B1 (fr) 2001-06-01 2003-09-12 Maco Pharma Sa Ligne de prelevement du sang placentaire comprenant une poche de rincage
US7179643B2 (en) 2001-06-14 2007-02-20 Reliance Life Sciences Pvt. Ltd. Device and a process for expansion of haemopoeitic stem cells for therapeutic use
EP1442115B9 (en) 2001-11-15 2009-12-16 Children's Medical Center Corporation Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
CA2470707C (en) * 2001-12-21 2014-07-08 Mount Sinai Hospital Cellular compositions and methods of making and using them
RU2205627C1 (ru) * 2002-05-30 2003-06-10 Открытое акционерное общество "Косметическое объединение "Свобода" Крем для лица, выводящий токсины
ES2584606T3 (es) 2002-10-10 2016-09-28 Ono Pharmaceutical Co., Ltd. Microesferas que comprenden ONO-1301
JP2006519250A (ja) 2003-03-04 2006-08-24 ファイザー・プロダクツ・インク 医療処置におけるｅｐ２選択的受容体アゴニストの使用
US20050054103A1 (en) * 2003-03-07 2005-03-10 Tony Peled Expansion of renewable stem cell populations using modulators of PI 3-kinase
AU2004227205B2 (en) 2003-04-08 2010-06-10 Yeda Research And Development Co. Ltd Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
GB0324523D0 (en) * 2003-10-21 2003-11-26 Medical Res Council Compositions and methods of treatment
US8309608B2 (en) 2003-11-06 2012-11-13 Sanofi-Aventis Deutschland Gmbh Use of eNOS transcription enhancers in the cell therapy of ischemic heart diseases
IL158868A0 (en) 2003-11-13 2004-05-12 Yeda Res & Dev Methods of generating and using stem cells enriched with immature primitive progenitor
US20070204351A1 (en) * 2004-01-14 2007-08-30 Davidson Bruce P Direct differentiation of cardiomyocytes from human embryonic stem cells
US20080299095A1 (en) * 2004-07-09 2008-12-04 Bc Cancer Agency Nup98-Hox Fusions for Expansion of Hemopoietic Stem Cells
US7147626B2 (en) 2004-09-23 2006-12-12 Celgene Corporation Cord blood and placenta collection kit
WO2006078886A2 (en) 2005-01-18 2006-07-27 Irm Llc Compounds and compositions as wnt signaling pathway modulators
WO2006086639A1 (en) 2005-02-10 2006-08-17 Regents Of The University Of Minnesota Vascular/lymphatic endothelial cells
WO2007117262A2 (en) 2005-07-29 2007-10-18 Athersys, Inc. Culture of non-embryonic cells at high cell density
JP4562618B2 (ja) 2005-08-18 2010-10-13 陽一 佐藤 空き缶処理車
RU2425876C2 (ru) 2006-03-24 2011-08-10 Чилдрен'З Медикал Сентер Корпорейшн Способ модулирования роста гематопоэтических стволовых клеток
CA2655807A1 (en) 2006-06-22 2007-12-27 Yeda Research And Development Co. Ltd Catecholamine receptor modulation
WO2008021475A2 (en) 2006-08-16 2008-02-21 The General Hospital Corporation Compositions and methods for hematopoietic stem cell expansion or for modulating angiogenesis
WO2008056963A1 (en) 2006-11-10 2008-05-15 Chanil Moon Method for proliferating stem cells with leptin
US9394520B2 (en) * 2006-12-08 2016-07-19 University Of Rochester Expansion of hematopoietic stem cells

Also Published As

Publication number Publication date
US10272110B2 (en) 2019-04-30
JP2015232010A (ja) 2015-12-24
US8563310B2 (en) 2013-10-22
WO2007112084A9 (en) 2007-11-22
CN102626517B (zh) 2015-07-29
JP2013155175A (ja) 2013-08-15
JP5247675B2 (ja) 2013-07-24
US8168428B2 (en) 2012-05-01
EP3424507A1 (en) 2019-01-09
US20130216507A1 (en) 2013-08-22
RU2425876C2 (ru) 2011-08-10
JP2019094347A (ja) 2019-06-20
JP6208719B2 (ja) 2017-10-04
JP2022025091A (ja) 2022-02-09
EP2423303A1 (en) 2012-02-29
JP2023112027A (ja) 2023-08-10
US20120189592A1 (en) 2012-07-26
JP2016210802A (ja) 2016-12-15
CA2647201C (en) 2016-03-08
CA2647201A1 (en) 2007-10-04
RU2493252C2 (ru) 2013-09-20
AU2007230902A1 (en) 2007-10-04
ZA200808123B (en) 2010-03-31
AU2007230902B2 (en) 2013-03-14
EP1999255A2 (en) 2008-12-10
JP6041711B2 (ja) 2016-12-14
JP2019214620A (ja) 2019-12-19
US20090285786A1 (en) 2009-11-19
US9028811B2 (en) 2015-05-12
AU2007230902A8 (en) 2009-07-23
JP6797222B2 (ja) 2020-12-09
MX2008012178A (es) 2009-01-23
ZA200906574B (en) 2010-06-30
RU2011115827A (ru) 2012-10-27
WO2007112084A3 (en) 2009-01-08
US8551782B2 (en) 2013-10-08
CN101495623A (zh) 2009-07-29
CN102626517A (zh) 2012-08-08
US20130209424A1 (en) 2013-08-15
RU2008142106A (ru) 2010-04-27
JP2009530408A (ja) 2009-08-27
WO2007112084A2 (en) 2007-10-04
US20120189593A1 (en) 2012-07-26
US20130209423A1 (en) 2013-08-15
WO2007112084A8 (en) 2008-11-20
JP6530732B2 (ja) 2019-06-12
HK1173948A1 (en) 2013-05-31
CN101495623B (zh) 2013-09-11
US20120189594A1 (en) 2012-07-26
US10278990B2 (en) 2019-05-07

Similar Documents

Publication Publication Date Title
MX2019007494A (es) Metodo para modular el crecimiento de celulas madre hematopoyeticas.
GEP20146053B (en) Compounds expanding hematopoietic stem cells
UA103623C2 (ru) Регулятор роста растений
MX2009008019A (es) Uso de nanoparticulas carotenoides dispersibles en agua como moduladores de sabor, moduladores de sabor que contiene nanoparticulas carotenoides dispersibles en agua y metodo para modulacion de sabor.
EP2048227A3 (en) Methods for proliferating stem cells
MY159971A (en) Multipotent/pluripotent cells and methods
MX2009004164A (es) Metodo para aumentar la regeneracion de tejido.
MY157445A (en) Compounds that modulate intracellular calcium.
IN2012DN02984A (es)
MX2009007266A (es) Formulaciones estables de acido s-(+)-abscisico liquidas y de granulo soluble.
MX345116B (es) Modulacion de bcl11a para tratamiento de hemoglobinopatias.
MX2010002712A (es) Compuestos que modulan calcio intracelular.
TNSN08024A1 (en) 7-substituted aza-indazoles, compositions containing same, production method and use thereof
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
ECSP099032A (es) Composiciones y métodos para la modulación del desarrollo vascular
TW200734462A (en) Regulating stem cells
WO2010129294A3 (en) Small molecules supporting pluripotent cell growth and methods thereof
CR20130184A (es) Composiciones bioactivas de chromobacterium y metabolitos
TW200628428A (en) High calcium fertilizer composition
MX2009005462A (es) Analogos de 7,8-saturados-4,5-epoxi-morfinano.
WO2010048358A3 (en) Ethoxyphenylmethyl inhibitors of sglt2
WO2009135905A3 (en) Mesenchymal stem cells and bone-forming cells
TW200942614A (en) Composition for modulating stem cell growth
MX2010005004A (es) Composiciones y dispositivos.
TW200624117A (en) 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs